TITLE

Can Open-Source Drug R&D Repower Pharmaceutical Innovation?

AUTHOR(S)
Munos, B.
PUB. DATE
May 2010
SOURCE
Clinical Pharmacology & Therapeutics;May2010, Vol. 87 Issue 5, p534
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Open-source R&D initiatives are multiplying across biomedical research. Some of them—such as public–private partnerships—have achieved notable success in bringing new drugs to market economically, whereas others reflect the pharmaceutical industry’s efforts to retool its R&D model. Is open innovation the answer to the innovation crisis? This Commentary argues that although it may likely be part of the solution, significant cultural, scientific, and regulatory barriers can prevent it from delivering on its promise.
ACCESSION #
49382832

 

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics